WallStreetZenWallStreetZen

NYSE: EBS
Emergent Biosolutions Inc Stock Ownership - Who owns Emergent Biosolutions?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Emergent Biosolutions Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Coleen GlessnerEVP Quality Ethics and CPL2025-04-07480$4.44
$2.13kSell
William HartzelSVP Bioservices2025-04-07561$4.44
$2.49kSell
Neal Franklin FowlerDirector2025-03-1235,000$5.83
$204.05kSell
Kathryn C. ZoonDirector2025-03-1210,000$5.73
$57.30kSell
William HartzelSVP Bioservices2025-03-05292$5.80
$1.69kSell
Coleen GlessnerEVP Quality Ethics and CPL2025-03-01313$7.48
$2.34kSell
Richard S. LindahlEVP Chief Financial Officer2025-03-01683$7.48
$5.11kSell
Paul Anthony WilliamsSVP Products Business2025-03-01116$7.48
$867.68Sell
Richard S. LindahlEVP Chief Financial Officer2025-02-281,073$7.48
$8.03kSell
Paul Anthony WilliamsSVP Products Business2025-02-28382$7.48
$2.86kSell

1 of 3

EBS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EBS insiders and whales buy or sell their stock.

EBS Shareholders

What type of owners hold Emergent Biosolutions Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri47.36%25,733,310$118.89MInsider
Intervac LLC8.00%4,344,250$20.07MInsider
Vanguard Group Inc5.89%3,200,700$14.79MInstitution
Biopharm LLC4.17%2,265,043$10.46MInsider
American Century Companies Inc3.93%2,137,712$9.88MInstitution
State Street Corp3.61%1,963,764$9.07MInstitution
Robert Calvin Myers3.56%1,934,849$8.94MInsider
Blackrock Inc3.54%1,922,836$8.88MInstitution
Biovac LLC2.94%1,599,155$7.39MInsider
Invesco Ltd2.83%1,539,907$7.11MInstitution

1 of 3

EBS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EBS41.15%58.85%Net SellingNet Selling
AQST43.87%7.62%Net SellingNet Selling
ACB8.84%0.00%
LFCR49.98%50.02%Net Buying
TKNO11.93%63.98%Net Buying
View Top Pharmaceutical Stocks

Emergent Biosolutions Stock Ownership FAQ

Who owns Emergent Biosolutions?

Emergent Biosolutions (NYSE: EBS) is owned by 63.93% institutional shareholders, 91.42% Emergent Biosolutions insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Emergent Biosolutions shareholder, owning 25.73M shares representing 47.36% of the company. Fuad Elhibri's Emergent Biosolutions shares are currently valued at $116.83M.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.